SHANGHAI, Aug. 4, 2026 /PRNewswire/ -- Innogen Pharmaceuticals (HK.2591), a biopharmaceutical company dedicated to innovative drug discovery and industrialization in metabolic diseases, today announced that its Efsubaglutide alfa manufacturing facility in Suzhou has officially passed a compliance inspection conducted by the Brazilian National Health Surveillance Agency (ANVISA) in accordance...
HONG KONG, July 7, 2026 /PRNewswire/ -- Master Concept Co-Founder Dennis Wong was invited to join the Citi Commercial Bank Hong Kong Executive Summit 2026...